Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record is now available, with details on the study’s terminated status, treatment arms, outcomes, eligibility criteria, participating locations, and study documents.SummaryDifference100%

- Check11 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA banner announces an NIH-wide terminology transition, and the site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov error page footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, preventing access to the study record and its related information. This indicates the content is temporarily unavailable to users.SummaryDifference18%

- Check60 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a software version update applied to the page rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.